Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype

Gut

Volumn 49, Issue 2, 2001, Pages 263-267

  Nakano, I ^a   Fukuda, Y ^a   Katano, Y ^a   Toyoda, H ^a   Hayashi, K ^a   Hayakawa, T ^a   Kumada, T ^b   Nakano, S ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Chronic hepatitis; Genotype 1b; Hepatitis C virus; Interferon sensitivity determining region; Interferon therapy

Indexed keywords

ALPHA INTERFERON; INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; SCORING SYSTEM; TREATMENT OUTCOME; VIRUS CHARACTERIZATION; VIRUS CLASSIFICATION; VIRUS LOAD;

ADULT; AGED; BLOOD TRANSFUSION; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEX FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0034918767     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.2.263     Document Type: Article

References (36)

1. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes
2. Chronic hepatitis C: The viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy
3. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha
4. Prediction of effect of interferon on chronic hepatitis C
5. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C
6. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment
7. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alpha-2b for 6 or 12 months: A 4-year follow-up of 211 patients
8. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b-sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
9. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients
10. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alpha
11. Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?
12. The origin of hepatitis C virus genotypes
13. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
14. Classification of chronic hepatitis: Diagnosis, grading and staging
15. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
16. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection
17. Risk factors for hepatocellular carcinoma and its incidence after treatment in patients with chronic hepatitis C
18. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
19. Hepatitis C virus genotypes: Epidemiological and clinical associations. Benelux study group on treatment of chronic hepatitis C
20. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors
21. Hepatitis C virus: Epidemiology and genotypes in the north of England
22. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy
23. Pathogenesis, natural history, treatment, and prevention of hepatitis C
24. The natural course of chronic hepatitis C: A comparison between patients with genotype 1 and 2 hepatitis C viruses
25. Natural history of liver fibrosis progression in patients with chronic hepatitis C
26. Hepatitis C virus type 1b (II) infection in France and Italy
27. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: Relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
28. Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy
29. Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: A randomized controlled trial
30. Interferon therapy in chronic hepatitis C virus infection
31. Therapy for chronic viral hepatitis
32. Hepatic iron strainings in chronic hepatitis C patients with low HCV RNA levels: A predictive marker for IFN therapy
33. Effectiveness of relative low-dose interferon treatment for patients with chronic hepatitis C
34. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis
35. Post-transfusion etiology and non-cirrhotic histology improve the remission rate of chronic hepatitis C during interferon treatment
36. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C